Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 50 (KRT18P50) is a nonfunctional genetic element associated with the keratin gene family, specifically named after the protein-coding keratin 18 gene. It belongs to the pseudogene classification, meaning it does not encode a protein and serves no direct role in cellular physiology or human disease. Pseudogenes like KRT18P50 are cataloged for genomic annotation but are not therapeutic, diagnostic, or prognostic targets. The canonical keratin 18 gene (KRT18), by contrast, is a major type I keratin involved in epithelial integrity, cellular stress response, and has established biomarker roles in oncology. No clinical relevance, drug interactions, or disease associations are attributed to KRT18P50 itself. The functional KRT18 gene is scientifically relevant and widely studied for its roles in cancer, apoptosis, and tissue maintenance. The pseudogene KRT18P50 is incorrectly considered as a target; it has no known protein expression, biological activity, or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 50 (KRT18P50).